Haris Hatic

Internal Medicine
2800 Buford Dr # 300
Buford, GA 30519

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin Lymphoma.

Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin Lymphoma.

Journal: Clinical lymphoma, myeloma & leukemia
Published: December 13, 2025

A Case of Nivolumab-Induced Bullous Pemphigoid-Successfully Treated with Rituximab.

A Case of Nivolumab-Induced Bullous Pemphigoid-Successfully Treated with Rituximab.

Journal: Journal of community hospital internal medicine perspectives
Published: November 27, 2025

Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma.

Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma.

Journal: Blood cancer journal
Published: July 15, 2025

Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era.

Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era.

Journal: Blood advances
Published: July 19, 2023

Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes.

Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes.

Journal: Haematologica
Published: January 19, 2023

Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma.

Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma.

Journal: American journal of hematology
Published: November 07, 2022

Clinical Outcomes in COVID-19 Patients Treated with Immunotherapy.

Clinical Outcomes in COVID-19 Patients Treated with Immunotherapy.

Journal: Cancers
Published: September 06, 2022

Time to first treatment is an independent prognostic factor for Multiple Myeloma (MM).

Time to first treatment is an independent prognostic factor for Multiple Myeloma (MM).

Journal: Leukemia research
Published: April 22, 2022

Patterns of Failure and Optimal Treatment Paradigm for Large, Inoperable, Node-Negative Non-small Cell Lung Cancer.

Patterns of Failure and Optimal Treatment Paradigm for Large, Inoperable, Node-Negative Non-small Cell Lung Cancer.

Journal: Clinical lung cancer
Published: February 18, 2022

Immune checkpoint inhibitors in lymphoma: challenges and opportunities.

Immune checkpoint inhibitors in lymphoma: challenges and opportunities.

Journal: Annals of translational medicine
Published: October 11, 2020

The Clinical Benefit of Adjuvant Therapy in Long-Term Survival of Early-Stage Ampullary Carcinoma: A Single Institutional Experience.

The Clinical Benefit of Adjuvant Therapy in Long-Term Survival of Early-Stage Ampullary Carcinoma: A Single Institutional Experience.

Journal: Journal of clinical medicine research
Published: July 08, 2020

Malignancy rate of atypia of undetermined significance/follicular lesion of undetermined significance in thyroid nodules undergoing FNA in a suburban endocrinology practice: A retrospective cohort analysis.

Malignancy rate of atypia of undetermined significance/follicular lesion of undetermined significance in thyroid nodules undergoing FNA in a suburban endocrinology practice: A retrospective cohort analysis.

Journal: Cancer cytopathology
Published: April 16, 2018
Showing 1-12 of 15

Last Updated: 09/26/2026